Published in Ann Intensive Care on April 13, 2011
Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Ann Intensive Care (2016) 1.39
Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin (2013) 1.19
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. PLoS One (2014) 1.13
Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care (2015) 1.01
Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis. Crit Care (2012) 0.94
Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun (2015) 0.87
Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg (2014) 0.85
Low-dose corticosteroid treatment and mortality in refractory abdominal septic shock after emergency laparotomy. Ann Intensive Care (2015) 0.84
ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock. J Immunol (2014) 0.83
Corticosteroids in the treatment of dengue shock syndrome. Infect Drug Resist (2014) 0.81
Novel adjunctive therapies for the treatment of tuberculosis. Curr Mol Med (2014) 0.80
The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update. Front Endocrinol (Lausanne) (2016) 0.78
A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics. Sci Rep (2016) 0.77
Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial. Trials (2014) 0.75
Vasopressin versus noradrenaline as initial therapy in septic shock. Is vasopressin-related renal protection doomed to "vanish" in the haze? Ann Transl Med (2016) 0.75
Evaluation of Hydrocortisone Continuous Infusion Versus Intermittent Boluses in Resolution of Septic Shock. P T (2017) 0.75
Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol (2017) 0.75
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med (1997) 14.51
Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med (2005) 8.65
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
Septic shock. Lancet (2005) 6.67
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest (2007) 5.55
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA (2009) 4.73
Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50
Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med (1999) 3.20
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17
Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med (2005) 3.09
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med (2002) 2.52
Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov (2004) 2.05
Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev (2004) 1.65
Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood (2006) 1.58
Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med (2008) 1.54
Effects of hydrocortisone on microcirculatory alterations in patients with septic shock. Crit Care Med (2009) 1.50
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol (1998) 1.34
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood (2005) 1.34
Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol (2008) 1.28
The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect (2009) 1.24
Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care (2002) 1.24
The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab (2008) 1.20
Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol (2006) 1.15
Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation (2006) 1.12
Ligand-specific glucocorticoid receptor activation in human platelets. Blood (2005) 1.12
Effect of cortisone on acute streptococcal infections and poststreptococcal complications. J Clin Invest (1951) 1.10
A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med (2010) 1.10
Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care (2007) 1.08
Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care (2010) 1.05
Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients. A prospective cohort study. J Cardiothorac Surg (2010) 1.00
Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med (2006) 0.94
Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg (2001) 0.94
Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock. Anesthesiology (2002) 0.93
Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock. Crit Care Med (2001) 0.91
Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood (2010) 0.91
Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care (2004) 0.91
Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J (2007) 0.88
Low-dose dexamethasone-supplemented fluid resuscitation reverses endotoxin-induced acute renal failure and prevents cortical microvascular hypoxia. Shock (2009) 0.88
Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation (2005) 0.87
Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity. Br J Pharmacol (2003) 0.82
Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality. Int J Clin Pharmacol Ther (2006) 0.81
Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock (1981) 0.78
Inhibition of release of tumor necrosis factor-alpha from human vascular tissue and smooth muscle cells by glucocorticoids. Crit Care Med (1997) 0.77
Surgical trauma-induced adrenal insufficiency is associated with postoperative inflammatory responses. J Nippon Med Sch (2007) 0.77